비비나비 : 워싱턴 DC : (미국) Washington DC

Final Rebate Reduction Request forms and instructions from IRA available for viewing; submission deadlines included



Centers for Medicare & Medicaid ServicesAnnouncement: Inflation Reduction Act and Medicare.

July 24, 2024

CMS Accepting Submissions from Drug Companies for Inflation Rebate Reductions

"The deadline for drug companies to submit a Likely to be in Shortage Rebate Reduction Request is August 2, 2024. The deadline for drug companies to submit a Severe Supply Chain Disruption Rebate Reduction Request is October 1, 2024"

The Rebate Reduction Requests under Sections 11101 and 11102 of the Inflation Reduction Act information collection request (ICR) forms are now final and available for viewing on OMB’s website [ https://www.reginfo.gov/public/do/PRAViewICR?ref_nbr=202405-0938-025 ].

Drug companies must complete the appropriate form(s) and provide supporting documentation as described in the ICR to be considered for a rebate reduction related to a severe supply chain disruption or likely shortage. Instructions on how to submit a request are included in the ICR and are available on the CMS website at https://www.cms.gov/inflation-reduction-act-and-medicare/inflation-rebates-medicare.

The deadline for drug companies to submit a Likely to be in Shortage Rebate Reduction Request is August 2, 2024, to receive consideration for a rebate reduction for a generic Part D rebatable drug for the applicable period that began on October 1, 2023. Likely to be in Shortage Rebate Reduction Requests submitted after August 2, 2024, will be considered for a rebate reduction for the next applicable period starting October 1, 2024. The deadline for drug companies to submit a Severe Supply Chain Disruption Rebate Reduction Request is October 1, 2024, for a natural disaster or other unique or unexpected event that occurred or began on or after January 1, 2023, but before August 2, 2024 (Part B rebatable biosimilar) or occurred or began on or after October 1, 2022, but before August 2, 2024 (generic Part D rebatable drug or biosimilar). Severe Supply Chain Disruption Rebate Reduction Requests for natural disasters or other unique or unexpected events that occurred or began on or after August 2, 2024, will be due on or after October 2, 2024.

Drug companies are not required to submit rebate reduction requests for Part B and Part D rebatable drugs listed as currently in shortage on an FDA shortage list.

Please email questions about this announcement to IRARebateandNegotiation@cms.hhs.gov.

Blue abstract shape.


________________________________________________________________________

You're getting this message because you subscribed to get email updates from the Centers for Medicare & Medicaid Services (CMS) [ http://www.cms.gov/ ].

Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page [ https://public.govdelivery.com/accounts/USCMS/subscriber/edit?preferences=true#tab1 ]. You will need to use your email address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com [ https://subscriberhelp.govdelivery.com/ ].

This service is provided to you at no charge by Centers for Medicare & Medicaid Services (CMS) [ http://www.cms.gov ].


________________________________________________________________________

This email was sent to mshinji3056@gmail.com using GovDelivery Communications Cloud 7500 Security Boulevard · Baltimore MD 21244


body .abe-column-block {min-height: 5px;}